TickerFacts.

Alzamend Neuro, Inc. (ALZN): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$8.07M
Year ended 2026-04-30
-$6.84M
Trailing 12 months to 2026-07-31
2020-04-30: -$2.35M2021-04-30: -$2.71M2022-04-30: -$6.61M2023-04-30: -$8.92M2024-04-30: -$8.27M2025-04-30: -$6.57M2026-04-30: -$8.07M-$8.07M
2020-04-30 Operating Cash Flow (USD) 2026-04-30
Period endedOperating Cash FlowChange YoYSource filing
2026-04-30-$8.07Mn/m2026-07-22, From 2025-05-01
2025-04-30-$6.57Mn/m2026-07-22, From 2024-05-01
2024-04-30-$8.27Mn/m2025-07-22, From 2023-05-01
2023-04-30-$8.92Mn/m2024-07-30, From 2022-05-01
2022-04-30-$6.61Mn/m2023-07-27, From 2021-05-01
2021-04-30-$2.71Mn/m2022-07-19, From 2020-05-01
2020-04-30-$2.35Mn/a2021-07-29, From 2019-05-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Alzamend Neuro, Inc. (ALZN)2026-04-30-$8.07Mn/m
Inhibitor Therapeutics, Inc. (INTI)2025-12-31-$3.23Mn/m
Accustem Sciences Inc. (ACUT)2025-12-31-$850.4Kn/m
Artelo Biosciences, Inc. (ARTL)2025-12-31-$8.52Mn/m
BullFrog AI Holdings, Inc. (BFRG)2025-12-31-$5.52Mn/m
Neonc Technologies Holdings, Inc. (NTHI)2025-12-31-$20.36Mn/m
Avenue Therapeutics, Inc. (ATXI)2025-12-31-$1.83Mn/m
Alaunos Therapeutics, Inc. (TCRT)2025-12-31-$2.87Mn/m
InMed Pharmaceuticals Inc. (INM)2026-06-30-$8.64Mn/m

Compare ALZN, INTI, ACUT, ARTL side by side · Screen every company in Pharmaceutical Preparations ↗